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in expression of these genes was a higher level of IL-8 in males compared
to females for MT (p < 0.0001) and MT+ACL tear (p < 0.05).
Fig. 1. Gene expression pattern in age-related meniscal tears with and
without concomitant ACL tear. All results presented here are statistically
signiﬁcant (p < 0.05) within each graph between the two categories.
Conclusions: Gene expression in meniscal tears varies by patient age, sex
and injury pattern. Our ﬁndings suggest that elevated expression levels
of OA-speciﬁc markers indicate an increased catabolic (inﬂammatory)
response in young patients with MT as well as MT+ACL tear. Furthermore,
higher expression of inﬂammatory markers in MT+ACL tear compared
to MT alone provide molecular evidence suggesting that the combined
injury pattern is more likely to lead to the development of OA. These
ﬁndings suggest clinically relevant differences in the response of the
knee to meniscus and ACL tears based on patient age and sex. Catabolic
activity may be predictive of patients at risk for progression of OA
following partial meniscectomy and ACL reconstruction.
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CALCIUM DEPOSITION AND GLYCOSAMINOGLYCAN PRESENCE IN
OSTEOARTHRITIC HUMAN MENISCAL ATTACHMENTS
A.C. Abraham, T. Haut Donahue. Michigan Technological Univ., Houghton,
MI, USA
Purpose: Meniscal attachments are unique graded tissue interfaces that
diffuse hoop stress from the meniscal body to the tibial plateau. Identiﬁed
enthesopathic alterations at other tissue interfaces have shown, amongst
other changes, an increase in water-afﬁne proteoglycan content, which
may result in extracellular matrix swelling and disruption of the ﬁber
network. If the attachments become structurally compromised, excessive
transverse meniscal extrusion results, and such extrusion is a known
precursor to knee osteoarthritis. Coupling this information with noted
catabolic activity within the arthritic joint gives rise to the supposition
that the meniscus-to-bone interface is a potential disease-forming
pathway, possibly predating other harbingers of degradation. To date
there have been no studies examining bio-chemical changes at this
interface.
Methods: Tibial plateaus from healthy (n =4) cadavers and patients with
end-stage knee osteoarthritis (n = 3) (undergoing total knee arthroplasty)
were obtained with IRB approval. All four (medial anterior, lateral
anterior, medial posterior, and lateral posterior) meniscal attachments
from ligamentous zone to subchondral bone were excised, ﬁxed in 10%
neutral buffered formalin, dehydrated in graded ethanol, and embedded
in glycol methacrylate. Specimens were sectioned using a diamond
wafering blade, ground using progressive SiC sheets on an autopolishing
wheel and cleared in xylene. Sections were stained using the Von Kossa
(VK) technique for calcium deposits and counterstained using toluidine
blue (TB) to identify glycosaminoglycans (GAG).
Changes in GAG presence in the insertion zones were quantiﬁed using
Bioquant OSTEO software to identify the thickness of the TB stained
and the TB+VK stained regions (Figure 1). Each region was outlined and
measurements were performed at 20mm intervals. Calcium deposition
was scored using a modiﬁed grading scale as described by Sun et al. 2010
(Table 1). Two blind reviewers examined each section independently and
results were averaged between them.
Fig. 1. (a) Gross inspection of insertion site reveals apparent calcium
deposition on the surface. TP – Tibeal Plateau, MB – Meniscal Body.
(b) Meniscal insertion stained for GAG and calcium. Yellow lines show the
regional identiﬁcation used for thickness measurements. AC – Articular
Cartilage, UFC – Uncalciﬁed FibroCartilage, CFC – Calciﬁed FibroCartilage.
Color thresholding (not pictured) used to aid in regional identiﬁcation.
(c) Fibrous attachment with no calcium deposition. (d) Calcium deposits
within the ﬁbrous attachment (left) and articular cartilage (right).
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Fig. 2. GAG Thickness measurements in the meniscal attachment.
Signiﬁcant differences were observed between the healthy and OA
samples in the uncalciﬁed fribocartilage thickness (*P < 0.05).
Table: Calcium deposit ranking scale, modiﬁed from Sun et al. 2010
Score Description
0 No calcium presence
1 Small calcium deposits around the exterior
2 Large deposits around the exterior
3 Calcium deposits around exterior and small deposits within the ﬁbrous attachment
4 Calcium deposits around exterior and large deposits within the ﬁbrous attachment
A two-way ANOVA considering attachment health and location was used
to examine differences in GAG thickness. A Wilcoxon rank sum test was
used to elucidate differences in calcium deposition between the healthy
and arthritic group of attachments.
Results: Signiﬁcant differences in measured GAG thickness between
the healthy and osteoarthritic attachments were observed (Figure 2),
however no differences were observed between attachment sites. The
calcium deposition of the OA samples demonstrated severe aggregation
of calcium within and around the ﬁbrous attachment. Accordingly,
calcium deposition was signiﬁcantly differently between groups using
the scoring system described (p < 0.01).
Conclusions: These results coincide with other pathological tissue
studies, revealing a localized increase in GAG thickness at the insertion
site as well as distinct calcium deposition in arthritic specimens
(Figure 1). This continues to build on the theory that calcium deposition,
while not necessarily causative, is an obvious result of OA. It is apparent
that proposed anti-calciﬁcation treatments would need to consider
the entire meniscus and its attachments as an entire functional unit.
Additionally, work within our laboratory has identiﬁed an increased
stiffness disparity at the interface at the interface using nano-indentation.
Future work will include performing calcium assays to quantify the
amount of deposition and also incorporating FE modeling to elucidate
the impact the calcium deposits and changes in mechanical properties
have on the integrity of the attachments.
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ANGIOGENESIS-RELATED CYTOKINE PROFILES IN PATIENTS WITH
ROTATOR CUFF DISEASE: HOW EFFECTIVE ARE SEROLOGICAL
MARKERS FOR EARLY DIAGNOSIS?
Y. Savitskaya, A. Izaguirre, F. Cruz, L. Sierra, E. Villalobos, A. Almazan,
C. Ibarra. Natl. Inst. of Rehabilitation, Mexico, Mexico
Introduction: Approximately 16% of the general population is believed
to have rotator cuff disease (RCD) at a given time. The hallmarks of
RCD the pathogenesis are inﬂammation, abnormal immune response,
angiogenesis and variables of vascularity. Avascular zones of tendons
are predisposed for degenerative changes and spontaneous rupture in
RCD. Decreased and increased vascularity might be involved in the
pathogenesis of degenerative tendon disease. In healthy individuals,
the cytokines synthesis of tendon increases in response to physical
activity, which results in stronger skeletal muscle and more resistant
connective tissue. Abnormalities in angiogenesis-related cytokines (ARC)
network of importance for the clinical signs and symptoms will be
focused on.
Objectives: To evaluate the diagnostic performance of serological tests
for early degenerative changes in RCD patients: the alterations in
endogenous ARC expression (IL-1beta, IL-6, IL-8, IL-10, VEGF, bFGF, ANG)
in the peripheral blood sera.
Methods: It is a prospective study of 200 patients with RCD (mean age
66.5). Patients were followed with clinical measures (UCLA, Constant,
WORC). MRI studies were performed on each shoulder. The control
group consisted of 200 age-, sex-matched healthy controls. Angiogenesis
imaging assays was performed using PDUS for evaluation the variables
of vascularity of the rotator cuff tendons. ARC proﬁles was performed
using Immunoassay kits (Bio-Plex Human Cytokine Assay; Bio-Rad
Inc., Hercules, CA, USA) per the manufacturer’s instructions, NIBSC’s
International Standards and ECBS’s recommendations of the World
Health Organization for of cytokine measurements.
Results: At time of inclusion the concentration of IL-1beta, IL-8, VEGF
was signiﬁcantly higher in RCD patients than in control. Serum VEGF
levels signiﬁcantly higher was found in 85% RCD patients studied.
The overexpression of VEGF correlated with advanced stage (r = 0.75;
p < 0.0005), aMVD (r = 0.68, p < 0.005) and VAS (r = 0.75, p < 0.0002) in
RCD patients. Serum ANG and IL-10 levels signiﬁcantly lower in RCD
patients versus control. Levels IL-1beta and ANG signiﬁcantly correlate
with degenerative tendon grade in RCD patients. No difference in IL-6 and
bFGF levels between RCD patients and control. Patients with degenerative
changes had very lower serum ANG levels compared with controls.
Combination of high VEGF and low ANG concentrations in the sera have
been considered as a predisposing factor for patients with ruptures of
rotator cuff tendons. PDUS examination revealed a high blood vessel
density in patients with tendon ruptures.
Conclusions: This investigation provides the ﬁrst standardized analytic
approach for assessing differences in ARC levels in the sera of RCD
patients. Our data demonstrated that uncontrolled pathogenesis of RCD is
associated with an imbalance between inﬂammatory, antiinﬂammatory
and vascular ARC. The future of ARC in clinical RCD application
requires close interactions between the public and private sectors:
the government, the pharmaceutical and biotechnology industries, and
academia.
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ANALYSIS OF MENISCUS USING FOURIER TRANSFORM INFRARED
IMAGING SPECTROSCOPY
H. Kuroki1, K. Tsuchimoto1, M. Kobayashi-Miura2, T. Aoyama1, A. Ito1,
K. Hashimoto3, M. Ishibashi1, S. Yamaguchi1, X.K. Zhang1. 1Dept. of Motor
Function Analysis, Graduate Sch. of Med., Kyoto Univ., Kyoto, Japan; 2Dept.
of Publ. Hlth., Faculty of Med., Shimane Univ., Izumo, Japan; 3Graduate Sch.
of Med., Tokyo Univ., Tokyo, Japan
Purpose: Fourier Transform Infrared Imaging Spectroscopy (FT-IRIS)
has been used to evaluate compositional and structural differences of
extracellular matrix (ECM) of cartilage. However, ECM of meniscus has
not been analyzed by FT-IRIS. Meniscus can be divided into two portions,
the central portion and the peripheral portion. The central portion is
designated the “white zone” (WZ), which is an avascular zone. The
peripheral portion is designated the “red zone” (RZ), which is a vascular
zone. The purpose of this study was to analyze differences of collagen
and proteoglycan in the extracellular composition of the WZ and the RZ
of meniscus using FT-IRIS analysis and biochemical assays.
Methods: Six menisci were removed from six porcine knees. The WZ
and the RZ of the menisci were analyzed using FT-IRIS analysis and
biochemical assays. In FT-IRIS analysis, the integrated area of amide I,
1710–1590 cm-1, for collagen and the area of sugar peak, 1150–950 cm-1,
for proteoglycan were calculated using the Spectra Manager ver. 2
software (Jasco Co. Japan). In biochemical assays, the WZ and the RZ
of the menisci were digested with RIPA buffer. Aliquots of the digests
were assayed separately with hydroxyproline content for collagen and
with dimethylmethylene blue (DMMB) for proteoglycan by quantifying
the amount of sulfated glycosaminoglycans. Mann-Whitney test was
used for statistical analysis. Correlation between the FT-IRIS data and
the biochemical data was evaluated with Spearman’s rank correlation
coefﬁcient. A P value <0.05 was considered to be signiﬁcant.
Results: According to the amide I area of FT-IRIS, collagen in WZ
(38.8±12.2 arbitrary units) was signiﬁcantly lower than that in RZ
(59.6±9.1 arbitrary units; P = 0.004). Hydroxyproline content in WZ
(2.65±1.95 ×104 mg/mL/cm3) was signiﬁcantly lower than that in
RZ (5.95±1.62 ×104 mg/mL/cm3; P = 0.024). There was a signiﬁcant
correlation (R2 =0.72) between the collagen estimated by amide I area
of FT-IRIS and the hydroxyproline content. According to the sugar area of
FT-IRIS, proteoglycan in WZ (5.5±1.71 arbitrary units) was signiﬁcantly
higher than that in RZ (3.38±2.24 arbitrary units; P = 0.03). Proteoglycan
